Related Experiment Video
Updated: Mar 27, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor
Joo-Young Im1, Kang-Woo Lee2, Kyoung-Jae Won3
1Genome Structure Research Center, KRIBB, Daejeon 305-806, Republic of Korea.
Abstract:
DNA damage induced apoptosis suppressor (DDIAS), or human Noxin (hNoxin), is strongly expressed in lung cancers. DDIAS knockdown induced apoptosis in non-small cell lung carcinoma A549 cells in response to DNA damage, indicating DDIAS as a potential therapeutic target in lung cancer. To understand the transcriptional regulation of DDIAS, we determined the transcription start site, promoter region, and transcription factor. We found that DDIAS transcription begins at nucleotide 212 upstream of the DDIAS translation start site. We cloned the DDIAS promoter region and identified NFAT2 as a major transcription factor (Im et al., 2016 [1]). We demonstrated that NFATc1 regulates DDIAS expression in both pancreatic cancer Panc-1 cells and lung cancer cells.
Insights
DNA damage induced apoptosis suppressor (DDIAS) is highly expressed in lung cancers. Targeting DDIAS, regulated by NFATc1, offers a potential therapeutic strategy for lung cancer treatment.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- DNA damage induced apoptosis suppressor (DDIAS), also known as human Noxin (hNoxin), is significantly expressed in lung cancer tissues.
- DDIAS plays a crucial role in cell survival, and its suppression can trigger apoptosis in cancer cells.
Purpose of the Study:
- To investigate the transcriptional regulation of DDIAS.
- To identify the transcription start site, promoter region, and key transcription factors involved in DDIAS expression.
- To explore the therapeutic potential of targeting DDIAS in lung cancer.
Main Methods:
- Cloning of the DDIAS promoter region.
- Identification of transcription start site.
- Analysis of transcription factor binding and regulation.
Main Results:
- The transcription start site for DDIAS was identified at nucleotide 212 upstream of its translation start site.
- NFAT2 was identified as a major transcription factor regulating DDIAS.
- NFATc1 was demonstrated to regulate DDIAS expression in both pancreatic and lung cancer cell lines.
Conclusions:
- DDIAS is a key regulator of apoptosis and is upregulated in lung cancer.
- NFATc1 is a critical transcription factor controlling DDIAS expression, presenting a potential therapeutic target.
- Understanding DDIAS regulation provides insights for developing novel lung cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Canonical Wnt Signaling Pathway

